Clinical Trial Detail

NCT ID NCT01309126
Title Study of Imprime PGG in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Biothera
Indications

rectum cancer

colon carcinoma

Therapies

Cetuximab

Cetuximab + PGG beta-glucan

Age Groups: adult

No variant requirements are available.